A Novel Parameter Derived from Platelet Histograms: Pre-Peak to Post-Peak Ratio and Its Correlation with Platelet Recovery in Thrombocytopenic Patients
Archives of Advances in Biosciences,
Vol. 17 No. 1 (2026),
28 April 2026
,
Page 1-8
https://doi.org/10.22037/aab.v17i1.51312
Abstract
Background and Aim: Automated hematology analyzers generate platelet indices and histograms that can provide insight into platelet dynamics. This study evaluates a novel parameter—the pre-peak to post-peak ratio from platelet histograms—and its associations with the percentage of giant platelet, standard platelet indices, and clinical recovery in patients with thrombocytopenia.
Methods: In an observational cohort study, 250 thrombocytopenic patients (platelet count <150,000/μL) were monitored over six days at a tertiary care center. Platelet histograms were analyzed using a 5-part automated hematology analyzer. The pre-peak/post-peak ratio was manually calculated, and its correlations with mean platelet volume (MPV), platelet distribution width (PDW), giant platelet percentage (from peripheral smears), and platelet recovery were assessed.
Results: Hyper-destructive thrombocytopenia predominated (82.4%, n=206), with dengue identified as the leading cause (53.9%). In these cases, giant platelet percentages surged by day 3 (p<0.001), positively correlating with post-peak length and inversely with the ratio. The ratio declined on day 3 and rose on day 6 in 82.4% of recovering patients. In contrast, hypo-productive cases (17.6%, n=44) showed no significant changes or correlations.
Conclusion: The pre-peak to post-peak ratio appears to be a simple and economical prognostic indicator for recovery in hyper-destructive thrombocytopenia, potentially guiding transfusion decisions and monitoring.
- hrombocytopenia
- Platelet histogram
- Giant platelets
- Mean platelet volume
- Platelet distribution width
- Platelet recovery
- Dengue
- Immune thrombocytopenic purpura
How to Cite
References
1. Jinna S, Karra S, Penney SW, Khandhar PB. Thrombocytopenia. StatPearls. 2025. (PMID)
2. Santoshi, Patel R, Patel NS, Bansro V, Chhabra G. A RK comprehensive review of thrombocytopenia with a spotlight on intensive care patients. Cureus. 2022 Aug;5(14):e27718. (DOI: 10.7759/cureus.27718) (PMID)
3. Jonsson AB, Rygård SL, Hildebrandt T, Perner A, Møller MH, Russell L. Thrombocytopenia in intensive care unit patients: A scoping review. Acta Anaesthesiologica Scandinavica. 2021 Jan;65(1):2–14. (DOI: 10.1111/aas.13699) (PMID)
4. Saran K, Vidya K, Seema K, Prasad A, Prakash J. Study of platelet indices and their role in evaluation of thrombocytopenia. Journal of Family Medicine and Primary Care. 2022 Oct;11(10):6236–42. (PMID)
5. Zhang Y, Wang Z, Zhou P, Zhang H. From reticulated platelets to immature platelet fraction: Structure, function, and clinical applications. Platelets. 2025 Dec;36(1).(DOI: 10.1080/09537104.2025.2467383) (PMID)
6. Ahmad W, Lubna Z, Mohsin A, Nishat A. Study of platelet indices in dengue fever with thrombocytopenia and correlation of immature platelet fraction (IPF) with platelet recovery. Archives of Hematology Case Reports and Reviews. 2020 Jan;5(1):001–5. (LINK )
7. Handtke S, Thiele T. Large and small platelets—(When) do they differ? Journal of Thrombosis and Haemostasis. 2020 Jun;18(6):1256–67. (DOI: 10.1111/jth.14788) (PMID)
8. Paul D, Pramanik AK, Biswas S, Das C, Islam MT. Evaluation of platelet indices in dengue fever in a tertiary care hospital in Bangladesh. International Journal of Advances in Medicine. 2023 Feb;10(3):223–7. (LINK)
9. Khazali AS, Hadrawi WH, Ibrahim F, Othman S, Nor Rashid N. Thrombocytopenia in dengue infection: Mechanisms and a potential application. Expert Reviews in Molecular Medicine. 2024 Oct;26:e26.(DOI: 10.1017/erm.2024.18) (PMID)
10. Cherie TJJ, Choong CSH, Abid MB, Weber MW, Yap ES, Seneviratne SL, et al. Immuno-haematologic aspects of dengue infection: Biologic insights and clinical implications. Viruses. 2024 Jul;16(7):1090. (DOI: 10.3390/v16071090) (PMID)
11. Senthil Nathan S, Varadaraj P, Nallusamy G, Reddy KSS. The Significance of Platelet Indices in the Evaluation of Thrombocytopenia. Cureus. 2024 Jul;16(7):e65756. (DOI: 10.7759/cureus.65756) (PMID)
12. Goel G, Semwal S, Khare A, Joshi D, Amerneni CK, Pakhare A, et al. Immature platelet fraction: its clinical utility in thrombocytopenia patients. journal of laboratory physicians. 2021 Sep;13(03):214–8. (PMID)
13. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 2007 May;39(2):175–91. (DOI: 10.3758/bf03193146) (PMID)
14. Azeredo EL de, Monteiro RQ, de-Oliveira Pinto LM. Thrombocytopenia in dengue: interrelationship between virus and the imbalance between coagulation and fibrinolysis and inflammatory mediators. Mediators of Inflammation. 2015 Jan;2015(1). (DOI: 10.1155/2015/313842) (PMID)
15. Ojha A, Nandi D, Batra H, Singhal R, Annarapu GK, Bhattacharyya S, et al. Platelet activation determines the severity of thrombocytopenia in dengue infection. Scientific Reports. 2017 Jan;7(1):41697. (DOI: 10.1038/srep41697) (PMID)
16. Parveen S, Vimal M. Role of platelet indices in differentiating hypoproductive and hyperdestructive thrombocytopenia. Annals of Pathology and Laboratory Medicine. 2017;4(3):A288–91. ( LINK)
17. Norrasethada L, Khumpoo W, Rattarittamrong E, Rattanathammethee T, Chai-Adisaksopha C, Tantiworawit A. The Use of Mean Platelet Volume for Distinguishing the Causes of Thrombocytopenia in Adult Patients. Hematology Reports. 2019 Mar;11(1):7732. (DOI: 10.4081/hr.2019.7732) (PMID)
18. Bhardwaj P, Kumari M, Kumar S, Kumar J. Analysis of platelet indices in various haematological and non-haematological disorders in a tertiary care institute. European Journal of Cardiovascular Medicine. 2025;15:187–92. (LINK)
19. Jeon K, Kim M, Lee J, Lee JS, Kim HS, Kang HJ, et al. Immature platelet fraction: A useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery. Medicine (Baltimore). 2020 Feb;99(7):e19096. (DOI: 10.1097/MD.0000000000019096) (PMID)
20. Ahmad J, Md Noor S, Mustapha SZ, Idris F. Estimation of a cut-off value for immature platelet fraction (IPF) in predicting platelet recovery in dengue patients with thrombocytopenia. Malaysian Journal of Pathology. 2022 Dec;44(3):499–508. (PMID)
21. Dadu T, Sehgal K, Joshi M, Khodaiji S. Evaluation of the immature platelet fraction as an indicator of platelet recovery in dengue patients. International Journal of Laboratory Hematology. 2014 Oct;36(5):499–504. (DOI: 10.1111/ijlh.12177) (PMID)
22. Chuansumrit A, Apiwattanakul N, Sirachainan N, Paisooksantivatana K, Athipongarporn A, Tangbubpha N, et al. The use of immature platelet fraction to predict time to platelet recovery in patients with dengue infection. Paediatrics and International Child Health. 2020 Apr;40(2):124–8. (DOI: 10.1080/20469047.2019.1697574) (PMID)
23. Looi KW, Matsui Y, Kono M, Samudi C, Kojima N, Ong JX, et al. Evaluation of immature platelet fraction as a marker of dengue fever progression. International Journal of Infectious Diseases. 2021 Sep;110:187–94. (DOI: 10.1016/j.ijid.2021.07.048) (PMID)
24. Abeysuriya V, Seneviratne SL, de Mel P, Clarice CSH, de Mel C, Chandrasena L, et al. The immature platelet fraction, a predictive tool for early recovery from dengue-related thrombocytopenia: A prospective study. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2022 May;116(5):424–32. (DOI: 10.1093/trstmh/trab135) (PMID)
25. Somia IKA, Purnamasidhi CAW, Shanti DAFP, Purnama GV, Adiputra IKH. Immature platelet fraction as a clinical predictor for enhanced platelet recovery in patients with dengue fever. One Health Bulletin. 2025 Sep;5(3):119–23. (DOI: 10.4103/ohbl.ohbl_48_24)
26. Ali I, Graham C, Dempsey-Hibbert NC. Immature platelet fraction as a useful marker in the etiological determination of thrombocytopenia. Experimental Hematology. 2019 Oct;78:56–61. (DOI: 10.1016/j.exphem.2019.09.001) (PMID)
27. Agarwal M, Bansal PK, Yadav ML. Utility of immature platelet fraction to predict platelet recovery in dengue patients having thrombocytopenia. International Journal of Advanced Medicine. 2021;8(3):410. (LINK)
28. Lee E, Kim M, Jeon K, Lee J, Lee JS, Kim HS, et al. Mean platelet volume, platelet distribution width, and platelet count, in connection with immune thrombocytopenic purpura and essential thrombocytopenia. Laboratory Medicine. 2019 Jul;50(3):279–85. (DOI: 10.1093/labmed/lmy082) (PMID)
29. Zulfania Z, Hayat H, Mahmood R, Bukhari AA, Ihtesham Y, Rasool U. Comparison of platelet indices in hypoproductive and hyperdesctructive thrombocytopenia. Pakistan Journal of Physiology. 2021 Jun;17(2):3–6. (LINK)
30. Francis R, Shetageri SN, A N R, Parthiban SRR. A study to evaluate use of platelet indices in hyperdestructive thrombocytopenia: a two-year experience from tertiary care rural hospital. Journal of Medical Sciences and Health. 2021 Jun;7(1). (LINK )
31. Guo L, Gu Y, Zhang Y, Zhang H, Weng W, Wu S, et al. Platelet dynamics and thrombocytopenia in dengue fever: A prospective cohort study from Shenzhen, China. New Microbes and New Infections. 2025 Oct;67:101624. (DOI: 10.1016/j.nmni.2025.101624) (PMID)
32. Pothapregada S, Kamalakannan B, Thulasingam M. Role of platelet transfusion in children with bleeding in dengue fever. Journal of Vector Borne Diseases. 2015 Dec;52(4):304–8. (PMID)
- Abstract Viewed: 56 times
- PDF Downloaded: 10 times